ICM
BLCO icon

Invenomic Capital Management’s Bausch + Lomb BLCO Stock Holding History

Invenomic Capital Management’s Portfolio BLCO Stock Details BLCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-762,451
Closed -$11.1M – 147
2024
Q2 		$11.1M Buy
762,451
+368,384
+93% +$5.53M 0.54% 65
2024
Q1 		$6.82M Buy
+394,067
New +$6.12M 0.36% 85
2023
Q2 		– Sell
-800,926
Closed -$13.9M – 137
2023
Q1 		$13.9M Sell
800,926
-75,448
-9% -$1.28M 0.79% 43
2022
Q4 		$13.6M Buy
876,374
+295,510
+51% +$4.44M 0.92% 34
2022
Q3 		$8.91M Sell
580,864
-16,481
-3% -$262K 0.77% 47
2022
Q2 		$9.1M Buy
+597,345
New +$9.68M 0.65% 51

Other funds holding BLCO

MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Invenomic Capital Management's BLCO Position: Q3 2024 in Review

Invenomic Capital Management sold out of Bausch + Lomb (BLCO) in Q3 2024, closing a stake of 762,451 shares — an estimated $11.1M sold.

Invenomic Capital Management first reported a position in BLCO in Q2 2022 and held it in 6 quarters. The position peaked at $13.9M in Q1 2023. 110 funds tracked by Wall St. Rank hold BLCO as of Q3 2024.

  • Invenomic Capital Management reported no remaining Bausch + Lomb position as of Q3 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 762,451 Bausch + Lomb shares in Q3 2024, an estimated $11.1M.
  • Invenomic Capital Management first reported a position in Bausch + Lomb in Q2 2022 and held it in 6 quarters.
  • Invenomic Capital Management's Bausch + Lomb position peaked at $13.9M in Q1 2023.
  • 110 funds tracked by Wall St. Rank held Bausch + Lomb as of Q3 2024.

Based on Invenomic Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.